GDT Summit 2025
STEP INTO THE FUTURE OF NON-INVASIVE HIGH-ENERGY THERAPY
Join the Global GDT Summit - A 2-Day Experience of Innovation, Expertise & Connection!
For over 25 years, EMS DolorClast® high-energy therapies have been trusted by tens of thousands of healthcare professionals worldwide, transforming millions of lives by helping people overcome musculoskeletal pain and reclaim active, pain-free living.
Now it’s your turn to be part of this movement.
The Swiss DolorClast® Academy, known for delivering one of the world’s most respected training programs, is taking education to the next level with the GDT Summit: an exclusive, immersive event designed for today’s pioneers and tomorrow’s leaders in high-energy therapy.
Why Attend?
Get inspired. Learn from the best. And lead the way.
Over two dynamic days, you’ll dive deep into the latest advancements in shockwave and laser therapy. Witness powerful clinical outcomes, discover ground-breaking case studies, and gain hands-on experience - all under the guidance of world-renowned experts.
Connect with a global community of forward-thinking healthcare professionals, exchange ideas, and bring fresh, evidence-based solutions to your practice.
GDT SUMMIT AGENDA
DAY 1
Shockwave Certification Day hosted by Prof Christoph Schmitz
8.00am - Registration & Check-In
9.00am - 3.00pm
Key Note Session 1
Key Note Session 2
Key Note Session 3
3.00pm - 4.30pm
Fireside Panel Session
DAY 2
Hands-On Practical & Case Studies
9.00am - 4.00pm
Workshops
TICKETS
Limited to 40 Tickets
EARLY BIRD SPECIAL
$599$499
10% Discount for
GDT CERTIFIED CLINICS
$599$449.10
GENERAL ADMISSION
Date
- 16 - 17 Aug 2025
Time
- 8:00 am - 4:00 pm
Cost
- $599.00
Locations
- VIC
Location
- Olympic Blvd, Melbourne VIC 3000
-
Website
https://centrepiecemelbourne.com/
Category
Trainer/Speaker
-
Prof Christoph Schmitz
-
Prof Dr Christoph Schmitz, MD, holds Chair II at the Department of Anatomy, Ludwig Maximilian University of Munich. He is a scientific advisor for the "Sportärztezeitung" and the scientific director of the continuing education series "Shockwave Therapy & Complementary Methods." In addition to his research on changes in the brain of patients with schizophrenia and autism, Prof Schmitz is deeply involved in researching the treatment of various conditions of the musculoskeletal system using extracorporeal shockwave therapy (ESWT) and, more recently, autologous stem cells. Currently, nearly 200 of his publications are indexed in PubMed. Two of his publications on ESWT for plantar fasciitis and knee osteoarthritis have received the highest rating ever achieved for ESWT studies in the PEDro database, with 9 out of 10 possible points.